The Company:
With deep expertise in chemistry, Nuvalent is working to create selective medicines designed with the goal to address the needs of patients with cancer. Nuvalent is an exciting early-stage company, bringing together experienced scientists and industry veterans with a proven track record in drug discovery, oncology drug development, and company building.
The Role:
Reporting to the Vice President, Commercial, The Vice President, Marketing will be a proven leader with deep expertise in oncology marketing, successful product launches, and team-building capabilities. This position will be responsible for developing and executing the brand strategy for zidesamtinib and neladalkib, potential best-in-class therapies for biomarker-directed NSCLC. The VP, Marketing will build and lead a comprehensive portfolio marketing plan while collaborating cross-functionally to ensure launch readiness.
Responsibilities:
• Develop and execute the brand strategy for zidesamtinib and neladalkib, ensuring launch readiness by 2026.
• Build a best-in-class marketing organization, encompassing product management, digital marketing, market access marketing, and thought leader liaisons.
• Lead brand development efforts, including brand identity, positioning, and messaging, in collaboration with Sales and Market Access teams to design a go-to-market strategy and launch plan.
• Oversee launch tactical planning for personal and non-personal promotion, leveraging innovative strategies to drive brand awareness and patient identification.
• Contribute to revenue forecast benchmarks, performance metrics, and assumptions to ensure effective strategic planning.
• Collaborate with Commercial Operations and other functions to create customer insights strategies, competitive monitoring plans, and market research frameworks.
• Ensure all marketing activities comply with company guidelines, local laws, and industry regulations throughout the launch and commercialization process.
• Partner closely with Commercial and Medical Affairs leadership to align on and execute brand strategy.
• Lead, mentor, and develop a high-performing marketing team, fostering collaboration across the organization and ensuring the successful execution of marketing initiatives.
• Serve as a key member of the U.S. Commercial leadership team, driving the strategic direction and achievement of company-wide goals.
Competencies Include:
• Foster a culture of empowerment, collaboration, and a focus on patient impact.
• Strong scientific and clinical orientation, comfortable with data, and ability to distill complex clinical information into business implications and credible narrative with internal and external stakeholders.
• Exceptional communication and influence skills, with the ability to inspire confidence and work successfully with varied stakeholders including the Brand Team and Product Development Team.
• Proficient in multichannel marketing directed towards HCPs and patients, including digital, media, peer-to-peer, congresses, and personal promotion tactics.
• Drives for results and nurtures a performance-based culture of continuous improvement, addressing concerns and conflict proactively.
• Characteristics include being entrepreneurial, collaborative, and an energetic initiative-taker with strong interpersonal and analytical skills.
Qualifications:
• Bachelor’s degree required; MBA or equivalent degree preferred.
• 15+ years of biopharma experience, including oncology product launch experience. NSCLC experience preferred.
• 5+ years of commercial oncology experience in the U.S. market, with expertise in data, analytics, and commercial operations.
• Proven ability to manage multiple projects simultaneously, prioritize effectively, and communicate at all organizational levels.
• Demonstrated success in recruiting, onboarding, managing, and retaining top talent, with a track record of developing and mentoring direct reports.
• Strong knowledge of analytics and operations tools and technologies.
• Excellent written, verbal, and presentation skills.
Willingness to travel domestically up to 20%.
Nuvalent provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to religion, race, creed, color, sex, sexual orientation, alienage or citizenship status, national origin, age, marital status, pregnancy, disability, veteran or military status, predisposing genetic characteristics or any other characteristic protected by applicable federal, state or local law.
Nuvalent is aware that many companies are dealing with fraudulent job postings on third-party employment search sites and/or individual(s) or entities claiming to be employees of such companies. Those involved are offering fraudulent employment opportunities to applicants, often asking for sensitive personal and financial information, and using such information for criminal activities.
Please be advised that all legitimate correspondence from a Nuvalent employee will come from "@nuvalent.com" email accounts. Automated system response emails from our Greenhouse applicant tracking system come from a “[email protected]” email address. There are no variations of these email addresses and Nuvalent would not request personal and/or financial information via email. Job opportunities would only be extended after a completed job application is submitted by a candidate and a thorough interview process including 1:1 and/or group interviews via phone, video conferencing and/or in-person.
If you believe you have been contacted by anyone misrepresenting themselves as an employee of Nuvalent, please contact Nuvalent at 857-357-7000. Thank you.
What We Do
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses. Nuvalent is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive NSCLC, along with multiple discovery-stage research programs. To learn more, visit www.nuvalent.com.
